{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:28:38Z","timestamp":1762867718418,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.endien.2022.07.006","type":"journal-article","created":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T08:28:36Z","timestamp":1661156916000},"page":"483-492","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Metabolic control and treatment regimens in patients with type 1 diabetes in Castilla-La Mancha, 10 years later: The 2020 DIACAM1 study"],"prefix":"10.1016","volume":"69","author":[{"given":"Julia","family":"Sastre","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro Jos\u00e9","family":"Pin\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florentino","family":"del Val","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"Moreno-Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Gonzalez L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iv\u00e1n","family":"Quiroga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Herranz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gema","family":"L\u00f3pez Gallardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dulce","family":"Calder\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"L\u00f3pez L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.endien.2022.07.006_bib0005","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa1610187","article-title":"Incidence trends of type 1 and type 2 diabetes among youths, 2002-2012","volume":"376","author":"Mayer-Davies","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.endien.2022.07.006_bib0010","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/S0140-6736(18)31320-5","article-title":"Type 1 diabetes","volume":"391","author":"DiMeglio","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.endien.2022.07.006_bib0015","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"Diabetes Control and Complications Trial Research Group","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.endien.2022.07.006_bib0020","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1056\/NEJMoa052187","article-title":"Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications (DCCT\/EDIC). Study Research Group Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes","volume":"353","author":"Nathan","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.endien.2022.07.006_bib0025","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1089\/dia.2019.2505","article-title":"New insulins, biosimilars, and insulin therapy","volume":"21","author":"Danne","year":"2019","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.endien.2022.07.006_bib0030","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/S0140-6736(19)31142-0","article-title":"Advances in technology for management of type 1 diabetes","volume":"394","author":"Beck","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.endien.2022.07.006_bib0035","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.amjms.2019.08.008","article-title":"Insulin pumps: review of technological advancement in diabetes management","volume":"358","author":"Sora","year":"2019","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.endien.2022.07.006_bib0040","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.ecl.2020.07.006","article-title":"New and emerging technologies in type 1 diabetes","volume":"49","author":"Sherwood","year":"2020","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.endien.2022.07.006_bib0045","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.endinu.2020.01.009","article-title":"Desarrollo de un \u00edndice de complejidad en consultas externas de Endocrinolog\u00eda y Nutrici\u00f3n","volume":"67","author":"Alfaro Mart\u00ednez","year":"2020","journal-title":"Endocrinol Diabetes Nutr"},{"key":"10.1016\/j.endien.2022.07.006_bib0050","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.endonu.2012.07.003","article-title":"Situaci\u00f3n de control metab\u00f3lico y pautas de tratamiento en pacientes con diabetes tipo 1 en Castilla-La Mancha: estudio de diabetes tipo 1 en Castilla-La Mancha","volume":"59","author":"Sastre","year":"2012","journal-title":"Endocrinol Nutr"},{"key":"10.1016\/j.endien.2022.07.006_bib0055","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.2337\/dc19-Srev01","article-title":"Summary of revisions: standards of medical care in diabetes\u20142019","volume":"42","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.endien.2022.07.006_bib0060","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.anpedi.2011.02.007","article-title":"Estudio epidemiol\u00f3gico de la diabetes tipo 1, en menores de 15 a\u00f1os en Castilla-La Mancha","volume":"76","author":"Giralt Mui\u00f1a","year":"2012","journal-title":"Ana Pediatr (Barc)"},{"key":"10.1016\/j.endien.2022.07.006_bib0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.endinu.2020.01.006","article-title":"Actividad asistencial en las consultas de Endocrinolog\u00eda y Nutrici\u00f3n de Castilla-La Mancha (estudio AACENCAM)","author":"Alfaro Mart\u00ednez","year":"2020","journal-title":"Endocrinol Diabetes Nutr"},{"key":"10.1016\/j.endien.2022.07.006_bib0070","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.endonu.2016.03.008","article-title":"Situaci\u00f3n cl\u00ednica de una cohorte de pacientes con diabetes tipo 1 m\u00e1s de 2 d\u00e9cadas despu\u00e9s del inicio. Resultados de un programa espec\u00edfico de seguimiento en una unidad de referencia","volume":"63","author":"Amor","year":"2016","journal-title":"Endocrinol Nutr"},{"key":"10.1016\/j.endien.2022.07.006_bib0075","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.endinu.2020.07.009","article-title":"La presencia de complicaciones microvasculares se asocia con un mal control metab\u00f3lico evolutivo en pacientes con diabetes tipo 1","volume":"68","author":"Carral","year":"2020","journal-title":"Endocrinol Diabetes Nutr"},{"key":"10.1016\/j.endien.2022.07.006_bib0080","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.endinu.2020.11.002","article-title":"Caracter\u00edsticas cl\u00ednicas y manejo de la diabetes tipo 1 en Espa\u00f1a. Estudio SED1","volume":"68","author":"G\u00f3mez-Peralta","year":"2021","journal-title":"Endocrinol Diabetes Nutr"},{"key":"10.1016\/j.endien.2022.07.006_bib0085","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1089\/dia.2018.0384","article-title":"State of type 1 diabetes management and outcomes from the T1D exchange in 2016\u20132018","volume":"21","author":"Foster","year":"2019","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.endien.2022.07.006_bib0090","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.diabres.2014.08.033","article-title":"Achievement of metabolic control goals set by the American Diabetes Association and the International Society for Pediatric and Adolescent Diabetes in pediatric patients with type 1 diabetes from Spain","volume":"107","author":"Enes","year":"2015","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.endien.2022.07.006_bib0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177210","article-title":"Socioeconomic inequalities in mortality, morbidity and diabetes management for adults with type 1 diabetes: a systematic review","volume":"12","author":"Scott","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.endien.2022.07.006_bib0100","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.diabres.2017.12.009","article-title":"A national survey on the efficacy and safety of continuous subcutaneous insulin infusion in patients with type 1 diabetes in Spain","volume":"137","author":"Beato-V\u00edbora","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.endien.2022.07.006_bib0105","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1089\/dia.2019.0097","article-title":"Continuous subcutaneous insulin infusion in adult type 1 diabetes mellitus patients: results from a public health system","volume":"21","author":"Moreno-Fernandez","year":"2019","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.endien.2022.07.006_bib0110","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1089\/dia.2009.0189","article-title":"Insulin pump use in Europe","volume":"12 Suppl 1","author":"Renard","year":"2010","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.endien.2022.07.006_bib0115","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1089\/dia.2020.0624","article-title":"CGM and glycemic control in Young Adults with Type 1 Diabetes: benefit for even the simplest insulin administration methods","volume":"23","author":"Toschi","year":"2021","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.endien.2022.07.006_bib0120","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.avdiab.2015.02.002","article-title":"Control gluc\u00e9mico y complicaciones cr\u00f3nicas a 20 a\u00f1os del comienzo de la diabetes tipo 1. Resultados de una unidad especializada","volume":"31","author":"Colom","year":"2015","journal-title":"Av Diabetol"},{"key":"10.1016\/j.endien.2022.07.006_bib0125","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.2337\/dc16-0502","article-title":"Coprogression of cardiovascular risk factors in type 1 diabetes during 30 years of follow-up in the DCCT\/EDIC study","volume":"39","author":"The Writing Group for the DCCT\/EDIC Research Group","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.endien.2022.07.006_bib0130","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/dom.13937","article-title":"Differences between patients with type 1 diabetes with optimal and suboptimal glycaemic control: a real\u2010world study of more than 30 000 patients in a US electronic health record database","volume":"22","author":"Pettus","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.endien.2022.07.006_bib0135","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ecl.2017.10.012","article-title":"Intensive diabetes treatment and cardiovascular outcomes in type 1 diabetes mellitus","volume":"47","author":"Subramanian","year":"2018","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.endien.2022.07.006_bib0140","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.endinu.2019.05.004","article-title":"Evaluaci\u00f3n y manejo del riesgo cardiovascular residual en el paciente con diabetes","volume":"67","author":"Gimeno Orna","year":"2020","journal-title":"Endocrinol Diabetes Nutr"},{"key":"10.1016\/j.endien.2022.07.006_bib0145","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1530\/EC-18-0546","article-title":"Incretin-based therapies for patients with type 1 diabetes: a meta-analysis","volume":"8","author":"Liu","year":"2019","journal-title":"Endocr Connect"},{"key":"10.1016\/j.endien.2022.07.006_bib0150","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1210\/jc.2013-2824","article-title":"Glycemic control and all-cause mortality risk in type 1 diabetes patients: the EURODIAB prospective complications study","volume":"99","author":"Schoenaker","year":"2014","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530018022001299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530018022001299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:16:21Z","timestamp":1762866981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2530018022001299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S2530018022001299"],"URL":"https:\/\/doi.org\/10.1016\/j.endien.2022.07.006","relation":{},"ISSN":["2530-0180"],"issn-type":[{"type":"print","value":"2530-0180"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic control and treatment regimens in patients with type 1 diabetes in Castilla-La Mancha, 10 years later: The 2020 DIACAM1 study","name":"articletitle","label":"Article Title"},{"value":"Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.endien.2022.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.endinu.2021.10.004","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 SEEN and SED. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}